PCI versus CABG: The Ongoing Feud
Search
Displaying 641 - 660 of 1578
Optimizing the Approach to Cardiovascular Genetics: Clinical, Translational and Teams
Home-grown Solutions for Cardiac Surgery in Africa: Meeting the needs of many
Perioperative Benzodiazepines: Should we use them in our patients?
Pre-emptive TAVI for Moderate Aortic Stenosis: Current status after TAVR unload
The Emerging Field of CardioObstetrics: What the Cardiologist Needs to Know
Dissecting Human Atherosclerosis with Multi-omics
2026 Spring Lecture Series
Spatially Mapping Atherosclerosis: Connecting Molecular Architecture to Clinical Understanding
CC/CHFS 2025 Guideline Update on the Pharmacological Management of Heart Failure with Non-reduced Ejection Fraction
Right Ventricular Monitoring. Dr. Denault will discuss the role of right ventricular (RV) pressure monitoring in cardiac surgery, describe how to diagnose RV dysfunction, RV failure and RV outflow tract obstruction and explore the effect of medications or interventions on RV pressure waveform monitoring.
Topic to be confirmed.
Dr. Martin Green is a Cardiologist at the University of Ottawa Heart Institute and Professor in the Department of Medicine at the University of Ottawa. His main interest is heart rhythm.
Marc-André Groulx is an Elected Director and Chair of the Ottawa Heart Institute Research Corporation(OHIRC) Board of Directors.
It was a cold, wintery morning on January 15 when a crowd of well-wishers joined numerous city and provincial dignitaries to celebrate the groundbreaking for the University of Ottawa Heart Institute’s expansion project. Many years in the making, the expansion will have a substantial impact on the...
Researchers at the Heart Institute say a diverse array of tools can help people quit e-cigarettes
Alexa Grudzinski, MD, is a cardiac anesthesiologist at the University of Ottawa Heart Institute and an assistant professor in the Faculty of Medicine at the University of Ottawa.
The Guideline-Directed Medical Therapy Clinic is a nurse-led clinic to help patients gradually increase the dosage of their heart failure medication to the target dosing. Heart failure medication has been proven to lower a patient’s risk of hospitalization and death when they have heart failure with reduced ejection fraction.
François Guimont is the Chair of the Board of Governors at the University of Ottawa.
Ming Hao Guo, MD, is a surgeon in the Division of Cardiac Surgery at the University of Ottawa Heart Institute (UOHI).